Finvest
STZ Beverage Alcohol · Consumer staples · Beer · Premium brands · Thesis updated July 12, 2026

Beer still leads, but demand must prove it

01 Running thesis

The beer test is back

Constellation is still mostly a beer story. Its U.S. license for Mexican beer brands such as Modelo and Corona is the heart of the business. Modelo Especial is listed by the company as the #1 beer brand in the U.S. by dollar sales.

The Q1 FY27 update made the story less clean. Beer net sales rose 2%, and shipments grew 1.8%. But depletions, which track product sold through distributors to the market, fell 0.3%. That gap matters because shipments can rise for a short time even if shoppers are not buying more.

The bull case needs the Q1 Beer depletion decline to be a small timing issue. If Beer depletions return to growth in Q2 or Q3, then the old view of a stabilizing beer franchise can still work. The reshaped Wine and Spirits business helps that case, since Q1 organic shipments rose 7.7% and organic depletions rose 6.6%.

The bear case is that Q1 was an early warning. If shoppers are pulling back on premium beer, distributors may end up with too much inventory. That could force lower shipments later and would hurt the main profit engine.

Jul 2026Q1 FY27 created a new concern in Beer. Shipments rose 1.8%, but depletions fell 0.3%, so the recovery now needs proof from consumer takeaway.
Apr 2026The FY2026 10-K showed Beer depletions down 2.1% versus shipments down 3.8%. That suggested the earlier distributor inventory correction was easing.
Jan 2026Q3 FY26 showed a clear stabilization sign. Beer shipment decline slowed to 2.2%, and organic U.S. wholesale shipments in Wine and Spirits grew 10.0%.
Oct 2025Q2 FY26 pushed the thesis into bear territory. Beer shipments fell 8.7%, and management pointed to softer consumers and distributor inventory reductions.
Jul 2025Q1 FY26 was a negative turn. Beer shipments fell 3.3%, Wine and Spirits organic shipments fell 13.3%, and the large wine divestiture closed.
Apr 2025FY2025 confirmed a split company: Beer was strong, while Wine and Spirits was weak. The company agreed to sell a large group of mainstream wine brands and recorded a $2.7407 billion goodwill impairment.
Jan 2025Beer remained the engine, while Wine and Spirits kept shrinking. The sale of SVEDKA for $409.2 million was an early step in fixing the portfolio.
02 Business model

Premium drinks, sold through distributors

Constellation makes and markets beverage alcohol. It sells beer, wine, and spirits to wholesale distributors, retailers, and places like bars and restaurants. The distributors then move the products to stores and on-premise locations.

The moat comes from brands and rights. In Beer, Constellation has an exclusive perpetual license to produce, import, market, and sell its Mexican beer portfolio in the U.S. That gives it control of a valuable slice of the high-end beer market.

Wine and Spirits is now a smaller, more focused business. The company sold much of its mainstream wine portfolio in 2025 and kept higher-end brands such as Robert Mondavi Winery, Kim Crawford, The Prisoner Wine Company, High West, and Casa Noble.

Where the model breaks is demand. Premium brands can earn strong margins, but only if consumers keep paying up. If shoppers trade down, drink less alcohol, or distributors cut orders, the company can feel it quickly.

03 Product portfolio

What sits on the shelf

Growth engine

Modelo Especial

Modelo Especial is the key beer brand and is described by the company as the #1 beer brand in the U.S. by dollar sales. It is central to the Beer segment's growth case.

Cash cow

Corona Extra

Corona Extra is another major imported beer brand in the U.S. license portfolio. It gives Constellation scale and brand power in premium beer.

Option

Alternative Beverage Alcohol

The Beer segment also includes ABA products. These give the company a way to test new drinking occasions, but they are not the core profit engine.

Steady

Robert Mondavi Winery

Robert Mondavi Winery is one of the higher-end wine brands left after the mainstream wine divestitures. It fits the move toward a smaller, premium portfolio.

Steady

Kim Crawford

Kim Crawford is a key remaining wine brand. Its role is to help prove that the slimmed-down Wine and Spirits segment can grow without the divested mainstream labels.

Steady

The Prisoner Wine Company

The Prisoner Wine Company is part of the premium wine focus. It supports the strategy of chasing higher-margin categories rather than volume for its own sake.

Option

High West and Casa Noble

High West and Casa Noble are the main spirits brands called out in the remaining portfolio. They give Constellation exposure beyond wine, but the segment is much smaller than Beer.

04 Business segments

Beer carries almost everything

Beer94%modest
Wine and Spirits6%growing fast

Mix is based on Q1 FY27 net sales: Beer was $2.2835 billion and Wine and Spirits was $149.2 million. Wine and Spirits reported sales fell after divestitures, so its small share hides better organic growth in the brands that remain.

05 Risk factors

What could go wrong

Beer demand fades

High impact · Medium odds

Beer is the main business, so even a small shift in consumer demand matters. Q1 FY27 showed shipments up 1.8% while depletions fell 0.3%. If that gap continues, the company may have shipped more beer than the market truly needed.

We watchBeer depletion growth in Q2 and Q3 FY27, especially whether it turns positive.

Distributor inventory correction

High impact · Medium odds

Shipments are sales into the channel. Depletions are closer to what consumers are taking out of the channel. If shipments keep running ahead of depletions, distributors may later cut orders to clear inventory.

We watchA quarter where Beer shipments fall below depletions after the Q1 FY27 gap.

Wine and Spirits reset disappoints

Medium impact · Medium odds

Constellation sold a large part of its mainstream wine business and is now betting on a smaller higher-end portfolio. Q1 organic growth was strong, but the reported segment is much smaller. The reset only works if the remaining brands keep growing and margins improve.

We watchOrganic Wine and Spirits shipments and depletions, plus segment operating income.

Premium alcohol loses occasions

Medium impact · Medium odds

The company lists changing consumer behavior as a risk, including weight loss regimens and GLP-1 drugs. If people drink less alcohol or spend less on premium drinks, Constellation's brand strength may not fully protect volumes.

We watchCompany comments on value-seeking behavior, alcohol moderation, and GLP-1 impact.

Leadership shift changes priorities

Medium impact · Low odds

Nicholas Fink became President and CEO in April 2026. The company has flagged CEO transition as a risk because a new leader can change strategy, spending, or capital allocation. For now, the open question is whether the beer-first, premiumization strategy stays intact.

We watchAny change in FY27 guidance, brewery spending plans, divestiture plans, or share repurchase pace.

Litigation over past wine strategy

Low impact · Medium odds

Shareholder lawsuits tied to statements about the Wine and Spirits strategy remain part of the background risk. The related derivative and class action complaints have been consolidated and stayed pending final judgment in the primary class action case. This is not the core operating risk, but it can still create cost and distraction.

We watchUpdates in Meza v. Constellation Brands and related stayed cases.
06 Quick answers

In one breath

Why is Constellation Brands mostly a beer company?

Beer made up about 94% of Q1 FY27 net sales. The most important assets are the U.S. rights to Mexican beer brands such as Modelo and Corona.

What are depletions for a beer company?

Depletions track product moving out of distributors toward retailers and consumers. They are useful because shipments can rise even when end demand is not improving.

Is the Wine and Spirits business still important?

It is much smaller after major divestitures, but it matters to the bull case. In Q1 FY27, organic shipments rose 7.7% and organic depletions rose 6.6%, which suggests the remaining premium portfolio is healthier.

What is the main thing to watch next?

Watch Beer depletions. If they turn positive in Q2 or Q3, the Q1 decline may look temporary. If they stay negative, the risk of a shipment correction rises.